New Metabolic Driver in Pancreatic Cancer Progression

A recent study identifies a specific metabolic pathway that alters how pancreatic ductal adenocarcinoma cells adapt to nutrient-poor environments, potentially changing therapeutic approaches.

The top 3

1. Key Metabolic Pathway Identified: Researchers discovered that elevated levels of the metabolite 2-hydroxyglutarate (2-HG) significantly enhance the survival of tumor cells in low-glucose conditions.
2. Impact on Tumor Growth Rate: In laboratory models, cells expressing this metabolic adaptation showed a 40% increase in growth rate compared to wild-type cancer cells when nutrients were restricted.
3. Clinical Implications for Patients: The findings suggest that targeting metabolic vulnerabilities could be a viable strategy for patients who do not respond to traditional chemotherapy regimens.

Sources

• National Cancer Institute

Open the full topic